Loading...

Cellebrite DI Ltd.

CLBT•NASDAQ
Technology
Software - Infrastructure
$12.70
$-0.03(-0.24%)
U.S. Market opens in 40h 59m

Cellebrite DI Ltd. (CLBT) Stock Overview

Explore Cellebrite DI Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.2B
P/E Ratio43.21
EPS (TTM)$0.31
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$14.20
3 Months$7.93
1 Year Target$13.75

CLBT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cellebrite DI Ltd. (CLBT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.75.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 43.21 and a market capitalization of 3.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.24%
5-Day Change
-2.46%
1-Month Change
-10.63%
3-Month Change
-19.97%
6-Month Change
-31.94%
Year-to-Date (YTD) Change
-29.56%
1-Year Change
-35.07%
3-Year Change
125.18%
5-Year Change
27.38%
All-Time (Max) Change
31.47%

Contact Information

https://www.cellebrite.com
972 73 394 8000
94 Shlomo Shmelzer Road, Petah Tikva, NaN, 4970602

Company Facts

1,167 Employees
IPO DateNov 6, 2020
CountryIL
Actively Trading

Frequently Asked Questions